zepbound tirzepatide weight loss results As FDA Approves Zepbound, Woman Shares Mounjaro Anyone considering switch to Zepbound
Description
Book an appointment with one of our board-certified primary care doctors to discuss options for your weight loss journey, including brand name GLP-1 and compounded semaglutide if you cannot access brand name medications
Brand approval sets the rules about who can get the medication based on FDA standards
The SURMOUNT-1 trial showed average weight loss of 20.9% at 72 weeks for the 15 mg dose group
At 20 mg/mL, it is 18.75 units, a quarter-unit measurement
